Citation Impact
Citing Papers
Cancer statistics, 2022
2022 Standout
Cancer statistics, 2023
2023 Standout
STAT inhibitors for cancer therapy
2013
Cancer treatment and survivorship statistics, 2022
2022 Standout
Cancer Statistics, 2021
2021 Standout
Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials
2010
Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells
2022 StandoutNobel
Cellular senescence in aging and age-related disease: from mechanisms to therapy
2015 Standout
Genetically engineered T cells for cancer immunotherapy
2019
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Developing Interventions for Cancer-Related Cognitive Dysfunction in Childhood Cancer Survivors
2014
Photodynamic therapy of cancer: An update
2011 Standout
Therapeutic modulators of STAT signalling for human diseases
2013
Geroscience: Linking Aging to Chronic Disease
2014 Standout
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
2014 Standout
Optimal therapy for acute lymphoblastic leukemia in adolescents and young adults
2011
Childhood and adolescent cancer statistics, 2014
2014 Standout
A small molecule STAT3 inhibitor, LLL12, enhances cisplatin‑ and paclitaxel‑mediated inhibition of cell growth and migration in human ovarian cancer cells
2020
Cognitive function and social attainment in adult survivors of retinoblastoma: A report from the St. Jude Lifetime Cohort Study
2014
Cancer treatment and survivorship statistics, 2016
2016 Standout
Cancer treatment and survivorship statistics, 2019
2019 Standout
Late Effects of Acute Lymphoblastic Leukemia Therapy in Patients Diagnosed at 0-20 Years of Age
2011
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
2015 Standout
LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy
2015
Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century
2010
Outcome of Photodynamic Therapy Using NPe6 for Bronchogenic Carcinomas in Central Airways >1.0 cm in Diameter
2010
A novel small inhibitor, LLL12, targets STAT3 in non‑small cell lung cancer in�vitro and in�vivo
2018
Works of Amanda Termuhlen being referenced
Small molecules, LLL12 and FLLL32, inhibit STAT3 and exhibit potent growth suppressive activity in osteosarcoma cells and tumor growth in mice
2011
Outcome of children less than three years old at diagnosis with non‐metastatic medulloblastoma treated with chemotherapy on the “Head Start” I and II protocols
2008
Comparison of long‐term outcome of children and adolescents with disseminated non‐lymphoblastic non‐Hodgkin lymphoma treated with COMP or daunomycin‐COMP: A report from the Children's Cancer Group
2001
Prognostic Significance of Interleukin-6 Single Nucleotide Polymorphism Genotypes in Neuroblastoma:rs1800795(Promoter) andrs8192284(Receptor)
2009
Predictors of Marriage and Divorce in Adult Survivors of Childhood Cancers: A Report from the Childhood Cancer Survivor Study
2009
Patterns of care among adolescents with malignancy in Ohio.
2006
Advances in cellular and humoral immunotherapy – implications for the treatment of poor risk childhood, adolescent, and young adult B‐cell non‐Hodgkin lymphoma
2019
High-Dose Methotrexate and Early Intensification of Therapy Do Not Improve 3 Year EFS in Children and Adolescents with Disseminated Lymphoblastic Lymphoma. Results of the Randomized Arms of COG A5971
2008